Poulton Jeffrey V. sold ALNY
January 12, 2026 · Form 4 insider transaction
Poulton Jeffrey V. sold 27 shares of Alnylam Pharmaceuticals, Inc. at $377.82 per share, a transaction worth $10.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
27
Price
$377.82
Total value
$10.2K
InsiderPoulton Jeffrey V.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 12, 2026
Filing dateJanuary 14, 2026
Shares owned after57,465
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement to cover minimum statutory tax withholding obligations.